Curium Pharma

Clinical Trials Day is celebrated annually on 20th May to honor the day in 1747 when James Lind started the first randomized clinical trial, a pivotal moment in medical research.  Listen to Dr. Amy Eccles shine a spotlight on the importance of clinical trials in developing life-changing treatments and join us recognising the professionals who are at the forefront of driving innovation in medicine. #NuclearMedicine #HealthcareInnovation #PatientCare #Curium #LifeForward #ClinicalTrials 

Meet Shauna McGauran, Lab Supervisor at Curium Ireland. Since joining Curium in 2018, Shauna has valued the unique nature of our work, the strong team spirit, and our shared commitment to putting patients first. Her advice for anyone considering a career at Curium: stay open to new challenges, work with honesty, and be ready for early mornings. Learn more about Curium’s careers: https://lnkd.in/dG_PztiU #LifeAtCurium #NuclearMedicine #Healthcare #TeamCurium #Innovation #Careers 

Curium drives innovation in nuclear medicine to improve patients' lives.   This is such a strong purpose statement that is underpinned by who we are and how we do it. We recently talked to our people across all areas of the business and from what we heard, we created our core values of Aim High, Win As One and Never Give Up.   These values resonate with us all and we are very proud of the culture we have at Curium. As we continue on our mission to treat up to 80% of cancers by 2040, we do it as one incredible team, globally.

The Curium team in Maryland Heights have given their time to volunteer at the St. Louis Area Foodbank Repacking Center as part of Curium Cares – our global initiative to give back to our community and charities that we support. Our team helped process donated food that will support soup kitchens, school pantries, and transitional housing organizations across the St. Louis region.  Coming together as a team to do something for the community makes such a difference to families facing food insecurity. #CuriumCares #CommunityImpact #Volunteerism #StLouis #Curium

If you are attending Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Los Angeles this year, pop in to hear Chaitanya Tatineni, CEO Curium Biopharma, in a panel discussion with other experts looking at investment in radiopharmaceuticals and specifically radioligand therapies.

We are excited to announce Curium’s participation at American Society of Clinical Oncology (ASCO) 2026 Conference. Our teams from Medical Affairs, Market Access, Neuroendocrine Tumor and Prostate Marketing will join the global oncology community in Chicago to exchange insights, foster collaboration, and highlight the growing role of nuclear medicine in cancer care. We are committed to driving innovation in nuclear medicine to improve patients’ lives. 📍 Meet us at Booth #22155 #ASCO2026 #Curium #NuclearMedicine #Oncology #RadioligandTherapy #PrecisionOncology #ProstateCancer #CancerCare #NETs #MolecularImaging #FutureOfOncology 

In nuclear medicine, reliability is not just an operational challenge — it’s part of patient care. Renaud. Dehareng, CEO Curium Group, explores why scaling theranostics depends not only on scientific innovation, but also on operational excellence across manufacturing, logistics, and delivery in an article with PharmaVoice. Read the full article below: https://lnkd.in/euc5pe6X #Curium #PharmaVoice #Theranostics #NuclearMedicine #Radiopharmaceuticals #PrecisionMedicine #Oncology 

Partnering with the Oncidium foundation is an important part of our mission to improve patients’ lives by providing access to diagnostics and treatments to ALL patients globally, including in low income countries. We are proud to both sponsor the Oncidium Foundation as well as contribute to the Radioligand Therapy initiative by donating our product to people in need. #NuclearMedicine #RadioligandTherapy #GlobalHealth #Oncology #RLTConnect

Society of Nuclear Medicine and Molecular Imaging (SNMMI) is in Los Angeles and we are ready! This year, more than 75 Curium colleagues from across our global teams will come together at SNMMI to connect, collaborate, and help advance the future of nuclear medicine. Join us at Booth #1323 throughout the congress and attend our key scientific session on Neuroendocrine Tumors  - Date: 2nd June  - Time: 6:45am - 7:45am Pacific Time. At Curium, every conversation starts with a patient-centric purpose and a commitment to innovation, clinical excellence, and meaningful scientific exchange. We look forward to seeing you in Los Angeles!   #SNMMI2026 #NuclearMedicine #MolecularImaging #PrecisionMedicine #Theranostics #MedicalImaging #Radiopharmaceuticals #HealthcareInnovation 

Theranostics is transforming cancer treatment and Curium have a bold ambition to treat up to 80% of cancers in the next 15 years. Delivering these therapies requires a truly connected approach and seamless co-ordination across manufacturing and distribution to supporting healthcare teams and patients. In the latest episode of The Top Line from Fierce Biotech, Curium’s CEO, North America, Michael Patterson, shares how access, safety and trust are key to expanding radiopharmaceutical treatments.    As theranostics moves beyond academic centers, workforce training, standardized practices and collaboration across the industry will be critical to improving access and patient experience. Listen to the full conversation to learn more: https://lnkd.in/dhJMxJKV #Theranostics #NuclearMedicine #Oncology #Radiopharmaceuticals #HealthcareInnovation #PatientCare #MedTech #CancerCare #Curium